FOS and ovarian carcinoma: The potential role of AP-1 and other transcription factors in regulating hTREX84 expression remain to be determined; however, our recent studies have shown that RelA/p65 plays a pivotal role in regulating hTREX84 expression in breast and ovarian cancer.